TREATMENT PATTERNS IN MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA REACHING STABILIZED MAINTENANCE WITH ONCE-MONTHLY PALIPERIDONE PALMITATE THERAPY

被引：1
|
作者：
Pilon, D. [1 ]
Muser, E. [2 ]
Emond, B. [1 ]
Xiao, Y. [1 ]
Amos, T. [2 ]
Lefebvre, P. [1 ]
Benson, C. [2 ]
机构：
[1] Grp Anal Ltee, Montreal, PQ, Canada
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1868
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH82
引用
收藏
页码：A196 / A196
页数：1
相关论文
共 50 条
  • [1] Predicting Factors for Reaching Stabilized Maintenance with Once-Monthly Paliperidone Palmitate in Medicaid Patients with Schizophrenia
    Muser, Erik
    Pilon, Dominic
    Emond, Bruno
    Xiao, Yongling
    Amos, Tony
    Lefebvre, Patrick
    Benson, Carmela
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 346 - 346
  • [2] TREATMENT PATTERNS AND MEDICAID SPENDING IN COMORBID SCHIZOPHRENIA POPULATIONS: ONCE-MONTHLY PALIPERIDONE PALMITATE VS ORAL ATYPICAL ANTIPSYCHOTICS
    Kamstra, R.
    Pilon, D.
    Lefebvre, P.
    Emond, B.
    Joshi, K.
    VALUE IN HEALTH, 2018, 21 : S180 - S180
  • [3] Treatment patterns and Medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics
    Kamstra, Rhiannon
    Pilon, Dominic
    Lefebvre, Patrick
    Emond, Bruno
    Joshi, Kruti
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (08) : 1377 - 1388
  • [4] Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate
    Lin, Dee
    Pilon, Dominic
    Zhdanava, Maryia
    Joshi, Kruti
    Lafeuille, Marie-Helene
    Cote-Sergent, Aurelie
    Vermette-Laforme, Maude
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 675 - 683
  • [5] Cost-effectiveness analysis of aripiprazole once-monthly versus paliperidone palmitate once-monthly in the treatment of schizophrenia in France
    Gozlan, G.
    Lecardeur, L.
    Monfort, A-S
    Doz, M.
    Ortiz, I
    Larroumets, P.
    Lafuma, A.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2018, 44 (06): : 496 - 503
  • [6] Once-monthly paliperidone injection for the treatment of schizophrenia
    Bishara, Delia
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 561 - 572
  • [7] Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia Relapse
    Zhdanava, Maryia
    Lin, Dee
    Lafeuille, Marie-Helene
    Ghelerter, Isabelle
    Morrison, Laura
    Lefebvre, Patrick
    Joshi, Kruti
    CLINICAL THERAPEUTICS, 2021, 43 (03) : 535 - 548
  • [8] Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
    Emond, Bruno
    Joshi, Kruti
    El Khoury, Antoine C.
    Lafeuille, Marie-Helene
    Pilon, Dominic
    Tandon, Neeta
    Romdhani, Hela
    Lefebvre, Patrick
    PHARMACOECONOMICS-OPEN, 2019, 3 (02) : 177 - 188
  • [9] Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
    Bruno Emond
    Kruti Joshi
    Antoine C. El Khoury
    Marie-Hélène Lafeuille
    Dominic Pilon
    Neeta Tandon
    Hela Romdhani
    Patrick Lefebvre
    PharmacoEconomics - Open, 2019, 3 : 177 - 188
  • [10] Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
    Lafeuille M.-H.
    Tandon N.
    Tiggelaar S.
    Kamstra R.
    Lefebvre P.
    Kim E.
    Yue Y.
    Joshi K.
    Drugs - Real World Outcomes, 2018, 5 (1) : 81 - 90
12345